CN1326750A - Traditional Chinese medicine for curing non-gonococcal urethritis - Google Patents
Traditional Chinese medicine for curing non-gonococcal urethritis Download PDFInfo
- Publication number
- CN1326750A CN1326750A CN 00108468 CN00108468A CN1326750A CN 1326750 A CN1326750 A CN 1326750A CN 00108468 CN00108468 CN 00108468 CN 00108468 A CN00108468 A CN 00108468A CN 1326750 A CN1326750 A CN 1326750A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- medicine
- rhizoma
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 208000000143 urethritis Diseases 0.000 title claims abstract description 25
- 239000002775 capsule Substances 0.000 claims abstract description 13
- 208000007190 Chlamydia Infections Diseases 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims description 6
- 241000218176 Corydalis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 16
- 241000204031 Mycoplasma Species 0.000 abstract description 10
- 206010028470 Mycoplasma infections Diseases 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 239000003826 tablet Substances 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000594394 Hedyotis Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 7
- 241000606161 Chlamydia Species 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000019802 Sexually transmitted disease Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- 208000001786 gonorrhea Diseases 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 241000606069 Chlamydiaceae Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000007963 capsule composition Substances 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004142 Bartholinitis Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000033464 Reiter syndrome Diseases 0.000 description 1
- 206010039954 Seminal vesiculitis Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010065584 Urethral stenosis Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 208000020426 gonococcal urethritis Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000002574 reactive arthritis Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000005582 sexual transmission Effects 0.000 description 1
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 description 1
- 229960004954 sparfloxacin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 201000001988 urethral stricture Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The traditional chinese medicine for treating non-gonococcal urethritis caused by mycoplasma and chlamydia infection is prepared with American ginseng, Astragalus membranaceus, Radix Sophorea Flavescentis, Herba Hedyotis Diffusae, Rhizoma Atractylodis and other 11 Chinese medicinal materials and through conventional traditional Chinese medicine preparing process. It may be prepared in bolus, medicine powder, tablet, capsule, oral liquid, etc. It has the functions of nourishing Yin, clearing away heat, strengthening body's resistance, promoting deuresis, treating strenguria, etc. and has excellent treating effect on non-gonococcal urethritis.
Description
The present invention relates to a kind of Chinese medicine for the treatment of the nongonococcal urethritis that mycoplasma, chlamydiaceae pathogen infection cause.
Nongonococcal urethritis (Non--gonecoccul urethritic, NGU), be meant because property contact and infectious urethritis all can not be found gonococcal symptom through checking its secretions repeatedly, comprise that also gonorrhea cures the persistent gonorrhea posterior urethritis of posterior urethritis symptom.This disease is a classification of the urethritis of sexual transmission.Cause that this sick main pathogens is that chlamydia trachomatis accounts for 40-50%, secondly for mycoplasma accounts for 20-30%, other pathogen are trichomonas vaginitis, herpes simplex virus, Candida albicans, Hemophilus vaginalis(Hemophilus vaginalis) and foreskin bacillus etc.
In clinical, to be that urethra is perverse itch for the nongonococcal urethritis that mycoplasma, chlamydiaceae pathogen infection cause, its classical symptom, with urgent micturition, dysurea, has slight or do not have dysuria, and urethral secretions is few or do not have, its urgent micturition, dysurea symptom than gonorrhea next gently.Morbidity slowly in a word, mild symptoms, longer duration be its Clinical symptoms.At present should disease have had first of sexually transmitted disease (STD).This disease can cause the multiple complications shape,, chronic prostatitis acute, epididymitis and seminal vesiculitis, urethral stricture, Reiter syndrome and female urethra inflammation, cervicitis, bartholinitis, urgent chronic pelvic inflammatory disease, proctitis as: non-gonococcal cowperitis, non-gonococcal, cause infertility even infection or hereditary offspring, not only, especially national quality is improved to constitute greatly and endanger for patient and family.Become global sexually transmitted disease (STD), the sickness rate height has become the common infectious disease of American-European countries since the seventies, exceeds more than the twice than the sickness rate of gonococcal urethritis.
And in Drug therapy, because chlamydia, mycoplasma substance volume are little, about 300-400 nanometer, it is the microorganism between antibacterial and virus, general sterilization Western medicine medicine is strong or owing to local blood drug level is not enough, topical remedy action time is long, the reasons such as appearance of drug resistance diseased plant to its specific aim, it is not thorough to sterilize, so cause intractable recurrence and infection again, general relapse rate is up to 3%.There are 10% chlamydia trachomatis and 30% carbamide mycoplasma that antibiotics is failed to respond to any medical treatment simultaneously approximately.Even so also can't effect a radical cure significant relatively Tetracyclines of its effect and macrolide antibiotic, up-to-date Sparfloxacin medicine also is affected suitable crowd, applicable elements because side effect is big, human internal organ such as Liver and kidney are destroyed damage.
The objective of the invention is to overcome the defective that exists in the prior art and provide a kind of based on motherland's traditional medical theory, contrast mycoplasma, the chlamydia infection symptom of nongonococcal urethritis with " pyretic stranguria " category of Chinese medicine and pharmacy, attached inspection means, compatibility meticulously with the modern times.Capture that three warmers are hot and suffocating, gas wins in kidney, diseases caused by exogenous pathogenic factor bacterial strain, flows into bladder, and then damp invasion of lower energizer causes a kind of Chinese medicine for the treatment of nongonococcal urethritis of nongonococcal urethritis, reaching virus killing sterilization, treating both the principal and secondary aspects of a disease, curative effect rapidly, short treating period, cure rate height, relapse rate be low, be suitable for the purpose that the crowd is wide, have no side effect.
Of the present invention theing contents are as follows
The present invention is on the basis of treatment " pyretic stranguria ", not only consider to invade the mark reality that damp and hot heresy is accumulate long-pending bladder outward, more consider the deficiency in origin of deficiency of the kidney, adopt the method for strengthening vital QI to eliminate pathogenic factors, make to set upright and do not love heresy, not eliminating evil just the wound, the science of carrying out compatibility is checked the cooperation of means, repeated screening through clinical summary and definite efficacy analysis and doctor trained in Western medicine, the chemical examination authentication, development cost invention medicine.
The basic composition of medicine of the present invention is to be effective ingredient (calculating according to weight) with following pharmaceutical composition:
Radix Panacis Quinquefolii: 10-30 part Radix Astragali: 30-50 part Rhizoma Smilacis Glabrae: 30-50 part
Radix Sophorae Flavescentis: 20-40 part Hedyotidis Diffusae: 20-40 part Rhizoma Atractylodis: 10-30 part
Rhizoma Coptidis: 7-19 part Calculus Bovis: 1-11 part Radix Paeoniae Rubra: 10-30 part:
Rhizoma Corydalis: 10-30 part Flos Lonicerae: 22-42 part Cortex Eucommiae: 20-40 part
Radix Salviae Miltiorrhizae: 30-50 part Cortex Phellodendri: 10-30 part Semen Plantaginis: 20-40 part
Fructus Gardeniae: 1-20 part
The preferred weight proportioning of each constituent of aforementioned pharmaceutical compositions is:
Radix Panacis Quinquefolii 10g Radix Astragali 20g Rhizoma Smilacis Glabrae 20g
Radix Sophorae Flavescentis 15g Hedyotidis Diffusae 15g Rhizoma Atractylodis 10g
Rhizoma Coptidis 6g Calculus Bovis 3g Radix Paeoniae Rubra 10g
Rhizoma Corydalis 10g Flos Lonicerae 16g Cortex Eucommiae 15g
Radix Salviae Miltiorrhizae 20g Cortex Phellodendri 10g Semen Plantaginis 15g
Fructus Gardeniae 5g
Aforementioned pharmaceutical compositions of the present invention, according to the process of Chinese medicine preparation of routine, can prepare becomes any endo-medicine dosage form commonly used, as: pill (big close ball, the watered pill, concentrated pill), powder, tablet, capsule, oral liquid etc.
The preparation method of medicine capsule of the present invention is: with above various medicines according to the rules proportioning choose medical material, cold water is cleaned,--dry in the sun--oven dry through dewatering, the pulverize separately powdered, mixing is crossed 120 mesh sieves, divides the capsule of packing into.The capsule specification is the 0.5g/ grain.
The effect of invention medicine, characteristics, superiority: medicine of the present invention has nourishing YIN and clearing away heat, strengthening the body resistance, dampness removing is treating stranguria, sterilization is eliminating evil, the effect of antitoxin detoxifcation, nourishing spleen and kidney, for the nongonococcal urethritis that causes by chlamydia, mycoplasma infection good therapeutical effect is arranged, clinical total effective rate reaches 99%, cure rate reaches 79%, clinical drug safety, the crowd of being suitable for is extensive, is subjected to the extensive patients favorable comment deeply.
Experimental example:
From year January in January, 1989 to 1999, treat nongonococcal urethritis patient 9698 examples altogether, male's 7564 examples, women's 2134 examples, the age is at 17-65 between year.Chlamydia infection 5876 examples wherein, mycoplasma infection 3720 examples, fungal infection 102 examples.Medical history is the longest 18 months, and is the shortest 1 month.All be through the invalid patient of western medicine.Through using capsule preparations of the present invention to carry out clinical treatment, obtain satisfied effect.Now be summarized as follows:
Clinical data:
1, case history choice criteria:
Patient is selected in diagnostic criteria according to Ministry of Public Health epidemic prevention department regulation.
Do not use medicine and other antibiotics of any treatment nongonococcal urethritis in (1) 1 week;
(2) there is tangible urethritis symptom the urethra part, and urethra is scratchy, scorching hot, causalgia, urine urgency-frequency, and purulence or mucus secretions are arranged;
(3) chlamydia, the mycoplasma positive are checked in the laboratory.
With year January in January, 1989 to 1999, treat nongonococcal urethritis patient 9698 examples altogether, male's 7564 examples, women's 2134 examples, the age is at 17-65 between year.Select chlamydia infection 5876 examples, mycoplasma infection 3720 examples.
2, Therapeutic Method and medication way
With capsule formulation of the present invention (mainly being made up of Radix Panacis Quinquefolii, the Radix Astragali, Poria, Radix Sophorae Flavescentis, Hedyotidis Diffusae, Rhizoma Atractylodis, Rhizoma Coptidis, Calculus Bovis, Radix Paeoniae Rubra, Rhizoma Corydalis, Flos Lonicerae, the Cortex Eucommiae, Radix Salviae Miltiorrhizae, Cortex Phellodendri, Semen Plantaginis, Fructus Gardeniae etc.) specification is the 0.5g/ grain; prepare into the scientific research medication by wide space andropathy in Zhengzhou City and infertility institute; each five; every day secondary; medication 20 days was a course of treatment, as required 2-3 course of treatment continuously.
In order to compare curative effect, the patient that will use western medicine the same period organizes in contrast.
3, criterion of therapeutical effect and efficacy analysis
Cure: the back clinical symptoms of taking medicine all disappears, and chemical examination chlamydia, mycoplasma are all turned out cloudy.
Produce effects: clinical symptoms disappears substantially after the medication, and the urethra sense of discomfort is arranged once in a while, but chemical examination detects chlamydia, mycoplasma is negative.
Invalid: clinical symptoms is obviously improved, but chemical examination detects chlamydia, mycoplasma is still positive.
4, therapeutic outcome
Clinical observation result shows, capsule treatment nongonococcal urethritis curative effect height of the present invention, and instant effect, non-evident effect, effective percentage are up to 99%, and its curative effect is apparently higher than antibiotic therapy group (seeing the following form in p＜0.05).Especially the mixed infection patient who delays for those obstinates, the state of an illness, and antibiotics drug resistance patient through after the treatment of 2-3 the course of treatment, also all obtains to cure.
Relatively group example number healing produce effects is invalid for the curative effect of capsule of the present invention and western medicine nongonococcal urethritis
The 9698 routine numbers of the routine number of routine number (%) (%) (%)
Capsule 9698 examples 7664 (79%) 1963 (20%) 71 (1%) of the present invention
Antibiotics 1352 examples 790 (58%) 268 (20%) 294 (22%)
Below in conjunction with embodiment medicine of the present invention is described further:
Be example with clinical use of capsule formulation:
Prescription:
Radix Panacis Quinquefolii 10g Radix Astragali 20g Rhizoma Smilacis Glabrae 20g
Radix Sophorae Flavescentis 15g Hedyotidis Diffusae 15g Rhizoma Atractylodis 10g
Rhizoma Coptidis 6g Calculus Bovis 3g Radix Paeoniae Rubra 10g
Rhizoma Corydalis 10g Flos Lonicerae 16g Cortex Eucommiae 15g
Radix Salviae Miltiorrhizae 20g Cortex Phellodendri 10g Semen Plantaginis 15g
Fructus Gardeniae 5g
Embodiment with the preparation method of capsule medicine is: with above various medicines according to the rules proportioning choose medical material, cold water is cleaned,--dry in the sun--oven dry through dewatering, the pulverize separately powdered, mixing is crossed 120 mesh sieves, divides the capsule of packing into.The capsule specification is the 0.5g/ grain.
Claims (1)
1; a kind of Chinese medicine for the treatment of nongonococcal urethritis; it is characterized in that: with Radix Panacis Quinquefolii 10-30 part; Radix Astragali 30-50 part; Rhizoma Smilacis Glabrae 30-50 part; Radix Sophorae Flavescentis 20-40 part; Hedyotidis Diffusae 20-40 part; Rhizoma Atractylodis 10-30 part; Rhizoma Coptidis 7-19 part; Calculus Bovis 1-11 part; Radix Paeoniae Rubra 10-30 part; Rhizoma Corydalis 10-30 part; Flos Lonicerae 22-42 part; Cortex Eucommiae 20-40 part; Radix Salviae Miltiorrhizae 30-50 part; Cortex Phellodendri 10-30 part; Semen Plantaginis 20-40 part; Fructus Gardeniae 1-20 part (above umber is weight) prescription; above-mentioned every kind of composition is carried out Chinese medicine processing according to the predetermined weight umber; can make endo-medicine dosage form commonly used; as: pill (big close ball; the watered pill; concentrated pill); powder; tablet; capsule; oral liquids etc. are made Chinese medicine patent medicine and are used for the treatment of a hope body; chlamydia infection causes nongonococcal urethritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00108468 CN1116049C (en) | 2000-06-07 | 2000-06-07 | Traditional Chinese medicine for curing non-gonococcal urethritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00108468 CN1116049C (en) | 2000-06-07 | 2000-06-07 | Traditional Chinese medicine for curing non-gonococcal urethritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1326750A true CN1326750A (en) | 2001-12-19 |
| CN1116049C CN1116049C (en) | 2003-07-30 |
Family
ID=4579210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00108468 Expired - Lifetime CN1116049C (en) | 2000-06-07 | 2000-06-07 | Traditional Chinese medicine for curing non-gonococcal urethritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1116049C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102935188A (en) * | 2012-11-03 | 2013-02-20 | 张敏 | Traditional Chinese medicine composition for treating candidiasis |
| CN102018790B (en) * | 2009-09-11 | 2013-07-10 | 叶景华 | Composition for curing urinary tract infection |
| CN103800756A (en) * | 2014-02-27 | 2014-05-21 | 徐晟伟 | Traditional Chinese medicine mixture for treating non-gonorrhea sexual genitourinary system infection caused by mycoplasma |
| US9295705B2 (en) * | 2010-11-08 | 2016-03-29 | Development Center For Biotechnology | Treatment for nephritis |
| CN106729321A (en) * | 2017-01-06 | 2017-05-31 | 朱以强 | A kind of prescription for treating NUG |
| CN107648516A (en) * | 2017-11-16 | 2018-02-02 | 河南中医药大学 | A kind of Chinese medicine for treating the chronic NUG of damp heat downward flowing type and preparation method thereof |
-
2000
- 2000-06-07 CN CN 00108468 patent/CN1116049C/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102018790B (en) * | 2009-09-11 | 2013-07-10 | 叶景华 | Composition for curing urinary tract infection |
| US9295705B2 (en) * | 2010-11-08 | 2016-03-29 | Development Center For Biotechnology | Treatment for nephritis |
| CN102935188A (en) * | 2012-11-03 | 2013-02-20 | 张敏 | Traditional Chinese medicine composition for treating candidiasis |
| CN103800756A (en) * | 2014-02-27 | 2014-05-21 | 徐晟伟 | Traditional Chinese medicine mixture for treating non-gonorrhea sexual genitourinary system infection caused by mycoplasma |
| CN106729321A (en) * | 2017-01-06 | 2017-05-31 | 朱以强 | A kind of prescription for treating NUG |
| CN107648516A (en) * | 2017-11-16 | 2018-02-02 | 河南中医药大学 | A kind of Chinese medicine for treating the chronic NUG of damp heat downward flowing type and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1116049C (en) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101049415A (en) | Preparation of Chinese traditional medicine for treating inflammation of department of gynecology | |
| CN1342462A (en) | Composite medicine for treating rheumatoid arthritis | |
| CN1872180A (en) | Medication of membranous milk vetch for activating blood and the channels, and preparation method | |
| CN1899500A (en) | Acne clearing decoction | |
| CN104173937A (en) | Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof | |
| CN100548354C (en) | A kind of oral liquid for the treatment of nephropathy | |
| CN1116049C (en) | Traditional Chinese medicine for curing non-gonococcal urethritis | |
| CN1057697C (en) | Powder for curing ulcerative colitis and proctitis ulcerosa | |
| CN1208646A (en) | Medicine for treating gastrointestinal ulcer and gastritis | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1051009C (en) | Chinese drug for treating chronic colitis | |
| CN1185000C (en) | Medicine for treating cyst | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1285380C (en) | Chinese patent medicines for treating chronic superficial gastritis (epigastric pain) and preparation method thereof | |
| CN101028491A (en) | Chinese-medicinal preparation for treating ribbon bleb | |
| CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
| CN1160102C (en) | Chinese medicine for curing female chronic inflammation | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN1185005C (en) | Medicine for treating inflammation | |
| CN1548065A (en) | Compound Chinese medicine for treating chronic pulvic infection and prepn process of its prepn forms | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN1088596C (en) | Chinese medicine with immunosuppression fuction for treating immunosterility (immunoacyesis) | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN1048901C (en) | Preparation for prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SANMENXIA GUANGYU PHARMACY CO., LTD. Free format text: FORMER OWNER: WANG GUANGYU Effective date: 20120925 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 450000 ZHENGZHOU, HENAN PROVINCE TO: 472400 SANMENXIA, HENAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120925 Address after: The western part of the Mianchi County Road Sanmenxia City, Henan province 472400 Patentee after: Sanmenxia Guangyu Biological Pharmaceutical Co., Ltd. Address before: 450000 No. 8 Renmin Road, Henan, Zhengzhou Patentee before: Wang Guangyu |
|
| CX01 | Expiry of patent term |
Granted publication date: 20030730 |
|
| CX01 | Expiry of patent term |